Dr Max Julvé
@JulveMax
Followers
526
Following
582
Media
32
Statuses
128
Clinical Research Fellow in Solid Tumour Cellular Therapies @RoyalMarsdenNHS I MD(res) Immuno-oncology @ICR_London l @NIHR ACF Medical Oncology SpR @ImperialNHS
London, England
Joined October 2018
Great to present some of my MD(res) data here at the @sitcancer Spring Scientific in San Diego. How do PD-L1 expressing neutrophils influence the efficacy of TIL therapy? 🧪. @ICR_London @royalmarsdenNHS @ajsfurness
0
5
26
RT @OncoDailyIO: Toxicity management strategies for solid tumour cell therapy - @JulveMax . @esmo_iotech @sophiawo….
0
4
0
Delighted to share our new paper reviewing toxicity management strategies for solid tumour cell therapy in @esmo_iotech . A great team effort from @sophiawongyn @DrJonLim @ajsfurness !.
1
2
24
Great IO and cell therapy fellowship opportunity in Manchester! ⬇️⬇️.
🆕 opportunity!. 🧑⚕️Interested in novel IO & cell therapy in solid cancer? Keen to gain experience in early phase trials?. Come join Fiona, me & our amazing team as a ‘Clinical Fellow in Advanced Immunotherapy & Cell Therapy Team’. Deadline 27 Nov 2024 👇.
1
2
5
RT @sophiawongyn: What a pleasure to be giving a talk with this panel on novel #immunotherapy #bispecifics #bites #cancervaccines #cellther….
0
3
0
RT @MiguelTICONA: @JulveMax @MelanomaPod @cdanicas @DrSapnaPatel @royalmarsdenNHS @DuncanGilbert11 @Adam_Hexter After UK 🇬🇧 vs Peru 🇵🇪 #ESM….
0
2
0
Great catching up with @DrJonLim and @sophiawongyn to discuss all things cellular therapy at #ESMO2024
0
0
9
A great evening thank you @cdanicas for organising. Congrats to team Ireland for winning against us on penalties in the final. 🇮🇪🇬🇧#ESMO24 @DuncanGilbert11 @Adam_Hexter @majbaxter @ZaydTippu
1
2
14
Team UK ESMO football team 🇬🇧🙌🏻.#ESMO2024 @MelanomaPod @cdanicas @DrSapnaPatel @royalmarsdenNHS @DuncanGilbert11 @Adam_Hexter
5
4
20
Any footballers coming to ESMO and wanting to play in the UK team please DM me! ⚽️🇬🇧⚽️🇬🇧.
🎯😎🎯😎… finally HABEMUS @myESMO football 2024 tournament!! .#ESMO24 @DrChoueiri @FAndreMD @ASCO . ⚽️🥅🏆🏆.👉 Saturday 14-9 .- 6.00 to 10.00 PM🔥🔥.- Some Teams are registered! .USA- France- Spain- Brasil -Argentina -Colombia - .Pending Germany? Peru? UK? Australia?.-
0
0
11
Exciting news to hear that the first genetically engineered solid tumour cellular therapy has just been granted accelerated approval by the @US_FDA! .
adaptimmune.com
0
0
4
Interim analysis for IGNYTE-ESO substudy 2- NYESO1 targeting TCR therapy for MRCLS and synovial sarcoma. ORR 40%, primary analysis expected end of 2024. Has been great being able to contribute to this important study at @royalmarsdenNHS #ASCO24
1
3
8
RT @DrBetofMDPhD: OBX-115 ORR 44% with 2 CRs! 100% DCR! This is SUPER exciting prelim efficacy and safety signal. Larger phase 1–>2 ongoing….
0
10
0
A pleasure presenting our novel granulocyte ratio (NEBR) melanoma data at #ASCO24. Lots of interesting discussion!. @sophiawongyn @ajsfurness @royalmarsdenNHS
0
8
36
Promising data from @IovanceBio COM202 (1st line TIL+pembro in MM). Small numbers (n=23) but ORR 65% and CR in 30%. Will be important to see how data from the larger TILVANCE study compares.
1
0
10
0
0
4